Science & Technology Advisory Committee

Tim Charlebois

SENIOR FELLOW AT NIIMBL, FORMER VICE PRESIDENT OF TECHNOLOGY AND INNOVATION STRATEGY AT PFIZER

Dr. Tim Charlebois retired from Pfizer after a 30-year career with the company including legacy companies Wyeth and Genetics Institute…

Mark Namchuk

EXECUTIVE DIRECTOR OF THERAPEUTIC TRANSLATION AT HARVARD MEDICAL SCHOOL

Mark Namchuk PhD is a professor of the practice of biological chemistry and molecular pharmacology and the executive director of…

Laurence Cooper

FORMER PROFESSOR MD ANDERSON, FORMER CHIEF EXECUTIVE OFFICER ZIOPHARM ONCOLOGY

Dr Laurence Cooper has contributed to the development of many therapies and cutting-edge technologies including in immuno-oncology where he developed and…

Beate Mueller-Tiemann

CHIEF TECHNOLOGY OFFICER, CYTIVA

Dr. Beate Mueller-Tiemann’s career has reflected the entire pharma value chain from early target discovery, lead generation, lead optimization, cell…

Andy Topping

CHIEF SCIENCE OFFICER, FUJIFILM DIOSYNTH BIOTECHNOLOGIES

Andy has worked in contract development and manufacture of biologics for almost 30 years. Originally trained as a molecular biologist…

Amy Wagers

PROFESSOR AND CO-CHAIR OF DEPARTMENT STEM CELL AND REGENERATIVE BIOLOGY, HARVARD UNIVERSITY

Dr. Amy Wagers’ substantial contributions to science, published in more than 150 primary research and review articles, have brought to…

Stacy Springs

EXECUTIVE DIRECTOR, MIT CENTER FOR BIOMEDICAL INNOVATION

Dr. Stacy Springs is the Executive Director at the MIT Center for Biomedical Innovation (CBI). The Center integrates the Institute’s…

Gregg Nyberg

CHIEF TECHNOLOGY OFFICER

Gregg Nyberg, Ph.D., brings more than 20 years’ biopharmaceutical industry experience to his new role at Landmark Bio. Most recently,…